Join
Live feed
·
INSIDERFilingvia Quantisnow
POINT Biopharma Global Inc. logo

Lubner David Charles returned 3,600 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PNT· POINT Biopharma Global Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PNT (POINT Biopharma Global Inc.) and more on Quantisnow.